rs11541998
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000219070.9(MMP2):āc.1842C>Gā(p.Pro614=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0987 in 1,613,442 control chromosomes in the GnomAD database, including 8,918 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. P614P) has been classified as Likely benign.
Frequency
Consequence
ENST00000219070.9 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMP2 | NM_004530.6 | c.1842C>G | p.Pro614= | synonymous_variant | 12/13 | ENST00000219070.9 | NP_004521.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMP2 | ENST00000219070.9 | c.1842C>G | p.Pro614= | synonymous_variant | 12/13 | 1 | NM_004530.6 | ENSP00000219070 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0736 AC: 11196AN: 152158Hom.: 511 Cov.: 32
GnomAD3 exomes AF: 0.0770 AC: 19332AN: 251108Hom.: 978 AF XY: 0.0787 AC XY: 10677AN XY: 135726
GnomAD4 exome AF: 0.101 AC: 148098AN: 1461166Hom.: 8407 Cov.: 36 AF XY: 0.0996 AC XY: 72387AN XY: 726898
GnomAD4 genome AF: 0.0735 AC: 11191AN: 152276Hom.: 511 Cov.: 32 AF XY: 0.0703 AC XY: 5233AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 10, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Multicentric osteolysis nodulosis arthropathy spectrum Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at